Matching slides 96,741
Current window 83,401-83,430
Pages 3,225
Rows per page 30
Component: Calloutclear collectionreset all

Component

83,401-83,430 of 96,741

filter-aware
32
The slide uses a flow diagram to show how business lines were re-categorized under the new corporate structure.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
33
The slide uses a bridge-style table to show how reported figures were adjusted to restated figures.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
41
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
42
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
43
Includes a callout highlighting 35% organic revenue growth for Global Solta.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
The slide highlights a 6% decline in WELLBUTRIN/APLENZIN revenue as a key driver.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
55
The slide includes two distinct tables: one for Revenue and one for Adj. Segment Profit/EBITA. It also includes a disclaimer about G&A and R&D allocation.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
58
The table includes a mix of quarterly and annual data columns.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
59
The table includes a 'New Segment Structure' callout and detailed footnotes regarding non-GAAP adjustments and segment realignment.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
60
The table includes a mix of quarterly and annual data columns.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
14
Uses a 'Before-After-Bridge' style narrative structure across three columns.Benson Hill | SPAC Presentation Deck | 57 slides · Benson Hill
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
21
The slide highlights both the genetic engineering (CRISPR) and the physical infrastructure (Crop Accelerator) components of their solution.Benson Hill | SPAC Presentation Deck | 57 slides · Benson Hill
Pitch deck Investment bank Beat · Solution1 hit
25
The slide uses a combination of a line chart showing protein progression and a comparison table to highlight the competitive advantage of Benson Hill's genetics.Benson Hill | SPAC Presentation Deck | 57 slides · Benson Hill
Pitch deck Investment bank Beat · Solution1 hit
27
The slide uses a linear process flow to describe the business scaling strategy.Benson Hill | SPAC Presentation Deck | 57 slides · Benson Hill
Pitch deck Investment bank Beat · Solution1 hit
35
The slide uses a hierarchical structure to show how different business segments contribute to the overall economic model, with a clear progression toward higher-margin royalty models.Benson Hill | SPAC Presentation Deck | 57 slides · Benson Hill
Pitch deck Investment bank 1 hit
36
The chart highlights a ~46% CAGR over the 2020-2027 period.Benson Hill | SPAC Presentation Deck | 57 slides · Benson Hill
Pitch deck Investment bank 1 hit
14
The slide uses a Gantt-style visualization to map drug candidates against clinical trial phases.BioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
29
BioNTech | Results Presentation Deck | 30 slidesBioNTech | Results Presentation Deck | 30 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
09
The slide combines two different metrics: growth percentages (left) and absolute revenue in millions (right).Broadridge Financial Solutions | Results Presentation Deck | 27 slides · Broadridge
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
12
The chart uses a waterfall bridge to explain the $65M increase in recurring revenue.Broadridge Financial Solutions | Results Presentation Deck | 27 slides · Broadridge
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
23
The chart uses a broken axis for the TAM bar to represent a significantly larger scale ($50B+) compared to the revenue bars ($4B range).Broadridge Financial Solutions | Results Presentation Deck | 52 slides · Broadridge
Conference presentation Investor relations Beat · KPIs OverviewLoop · Logic Chain1 hit
34
The chart combines growth percentages (FY18-FY21) and absolute revenue figures (Q3'20-Q3'21).Broadridge Financial Solutions | Results Presentation Deck | 52 slides · Broadridge
Conference presentation Investor relations 1 hit
37
The chart uses a waterfall bridge format to explain the $65M increase in recurring revenue.Broadridge Financial Solutions | Results Presentation Deck | 52 slides · Broadridge
Conference presentation Investor relations 1 hit
41
Includes a specific callout for the $2.5B Itiviti acquisition.Broadridge Financial Solutions | Results Presentation Deck | 52 slides · Broadridge
Conference presentation Investor relations 1 hit
11
The slide uses a three-column layout to summarize the company's core value proposition.Centessa | IPO Presentation Deck | 33 slides · Centessa Pharmaceuticals
Pitch deck Investment bank Beat · Market Size1 hit
17
The slide uses a three-column layout to summarize the company's core value proposition.Centessa | IPO Presentation Deck | 33 slides · Centessa Pharmaceuticals
Pitch deck Investment bank 1 hit
23
Includes both longitudinal dosing data and endpoint histology/biomarker analysis.Centessa | IPO Presentation Deck | 33 slides · Centessa Pharmaceuticals
Pitch deck Investment bank 1 hit
09
The slide uses a bubble chart to visualize job vulnerability. A central callout box provides supporting evidence from the World Economic Forum.Coursera | Results Presentation Deck | 32 slides · Coursera
Conference presentation Investor relations Beat · Problem Statement1 hit
09
The slide uses a Venn diagram to illustrate the intersection of Value, Plan, and Path to define an 'Attractive Target'.Cyxtera | SPAC Presentation Deck | 64 slides · Cyxtera
Conference presentation Investment bank 1 hit
14
The chart uses a 5-year CAGR of 8% and highlights carrier-neutral colocation as the 'sweet spot'.Cyxtera | SPAC Presentation Deck | 64 slides · Cyxtera
Conference presentation Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit